Ridgetech Inc. (RDGT)
Healthcare
- Fundamental
- 3
- Sentiment
- 3
- Technical
- 2
Do Nothing: RDGT passes price, fundamental, liquidity, and event checks, but technicalScore is 2 and the chart shows a failed high-volume spike / range-expansion attempt with price below VWAP; wait for a cleaner base or a fresh reclaim of resistance before considering a long.
Company overview
Ridgetech Inc. is a holding company managing subsidiaries involved in the wholesale, distribution, and retail sales of pharmaceutical and health-related products. The company is transitioning from retail to a wholesale and online distribution model.
Fundamental
fairRidgetech's fundamentals are mixed, with improved liquidity but volatile profitability and regulatory constraints.
Ridgetech is a China-based pharmaceutical distributor transitioning from retail to wholesale/online distribution. FY2025 revenue was $120.0M and the FY2021–FY2025 revenue CAGR is about -2.57%; profitability is volatile with very thin margins (TTM gross margin about -7.43% and EBITDA margin about 5.97%). Liquidity is better: SEC filings describe positive working capital (~$25M), access to bank credit facilities, and improved operating cash flow in the latest interim period. Official disclosures highlight PRC regulatory/cash-transfer constraints, customer concentration, and material weaknesses in internal controls—keeping the fundamental outlook mixed.
Sentiment
fairSentiment is neutral with no immediate catalysts, and media focus remains on insider transactions.
Last ~14d media sentiment is near-neutral (slightly negative) and improved versus the bearish 30–90d reverse-split/52-week-low baseline, but the only actionable developments are mixed 10% holder/insider buy vs sell headlines (confidence: announced). Conflicting short-term signals trigger a moderate red-flag cap at 3, while the legal/regulatory screen shows no active investigations.
Technical
weakTechnical indicators show a failed breakout with weak momentum and high volatility.
RDGT regained short-term moving-average support, but the 2026-06-23 tape behaved like a blow-off spike instead of a controlled breakout. RSI14 at 36.01 and Williams %R at -76.67 remain weak, MACD is still below zero despite a positive histogram, and the stock faded well below daily VWAP 2.13 on outsized volume.
You’re looking at 2026-06-23 — about 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.